Christopher Cox is a Co-Founder and a General Partner of Population Health Partners, L.P., a global healthcare focused investment firm, since April 2020. Chris serves on the boards of Scientific Industries (SCND-OTXQB), a manufacturer of laboratory instruments; Niroda Therapeutics, a private biopharmaceutical company focused on the development and commercialization of non-opioid therapeutics for acute and chronic pain; and Civia Health, a private clinical trial site management organization.

Previously, from January 2012, Chris was a partner, Chairman of the Corporate Department, and a member of the management committee of Cadwalader, Wickersham & Taft LLP, a global law firm. From February 2016 to March 2019, Chris served as Executive Vice President and Chief Corporate Development Officer of The Medicines Company, a global biopharmaceutical company, where he was responsible for business development and strategy.